| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $83K | — |
| R&D Expense | $52K | — |
| SG&A Expense | $53K | — |
| Pre-tax Income | -$23K | — |
| Income Tax | $0 | — |
| Net Income | -$23K | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23K | +467.0% |
| Current Assets | $63K | +1451.3% |
| Total Assets | $68K | +1577.9% |
| Current Liabilities | $26K | +3027.6% |
| Total Liabilities | $26K | +3027.6% |
| Stockholders' Equity | $42K | +1208.6% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38K | — |
| Investing Cash Flow | -$6K | — |
| Financing Cash Flow | $63K | — |